Uncategorized
Omeros reports $20.5 million net loss in first quarter
Omeros reported a net loss of $20.5 million, or $0.54 per share, in the first quarter compared with a net loss of $18.7 million, or $0.51 per share, in the same quarter of 2015, according to a press release. Total revenue was reported at $7.4 million in the first quarter, which included $7.2 million in sales from Omidria (1% phenylephrine and 0.3% ketorolac injection). In the same quarter of 2015, total revenue was $388,000, which included $238,000 in sales from Omidria.